Objective This study aimed to evaluate fetal epicardial fat thickness (EFT) along with fetal myocardial performance index (MPI) and its effects on perinatal outcomes in non‐severe idiopathic polyhydramnios (IP). Materials and Methods This prospective study included 92 participants, 32 diagnosed with non‐severe IP, and 60 healthy pregnant women. Amniotic fluid indices (AFI), umbilical and middle cerebral artery Doppler, EFT, and MPI measurements were performed for all patients. Results The fetal EFT and MPI values were statistically higher in the non‐severe IP group than in the control group (p = 0.0001, p = 0.014, respectively). The optimal fetal EFT cutoff value for predicting non‐severe IP disease was found as 1.3 mm with a specificity of 81.7% and sensitivity of 59.4%. The EFT cutoff for predicting cesarean section in non‐severe IP cases was 1.25 mm (p = 0.038). Apgar scores, neonatal intensive care unit, respiratory distress syndrome, and stillbirth rates were not different between groups. Conclusion In this study, EFT and MPI were found to be higher in non‐severe IP cases compared to controls. It was observed that the increase in MPI and EFT was associated with the increase in cesarean rates, but not with adverse fetal outcomes.
PRECIS: In gynecologic cancer surgeries, using loupe glasses is beneficial in decreasing lymphocele formation, amount of lymphatic drainage, and hemoclip use. Öz Amaç: Bu çalışmada cerrahide büyüteçli gözlük kullanımının cerrahi sonuçlar ve lenfosel oluşumu üzerindeki etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntemler: Çalışmaya pelvik ve para-aortik lenf nodu disseksiyonu yapılan 36 jinekolojik kanser hastası prospektif olarak dahil edildi. Yaş, vücut kitle indeksi, menopozal durum, kanser tipi, ek hastalıkların varlığı, operasyon öncesi albumin düzeyi ve albümin replasmanı, performans durumu, serumda CA125, hemoglobin, platelet ve beyaz küre sayısı, cerrahi prosedür, kan kaybı miktarı, kan transfüzyonu ihtiyacı, çıkarılan lenf nodu sayısı, metastatik lenf nodu varlığı, toplam drenaj miktarı, operasyon sonrası komplikasyonlar, operasyon süresi ve kullanılan hemoklip sayısı kaydedildi. Hastalar cerrahi sırasında büyüteçli gözlük kullanılan ve kullanılmayan olarak iki grupta randomize edildi. Bulgular: Büyüteçli gözlük kullanılmayan grupta, toplam drenden gelen miktar 6698 mL iken büyüteçli gözlük kullanılan grupta sadece 1049 mL olarak tespit edildi (p<0,01). Cerrahi sonrası drenin kalış süresi büyüteçli gözlük kullanılmayan grupta 10,6±5,1 gün, büyüteçli gözlük kullanılan grupta 4,8±2,4 gün olarak bulundu (p=0,0001). İki grup arasında cerrahi alan enfeksiyonu, fasya defekti ve pulmoner emboli açısından anlamlı fark bulunmadı (sırasıyla: p=0,39, 0,33, 0,59). Büyüteçli gözlük kullanılan ve kullanılmayan grupta çıkarılan lenf nodu sayısında da anlamlı fark bulunmadı. Kullanılan hemoklip sayısı büyüteçli gözlük kullanılmayan ve kullanılanlarda sırasıyla 50,22±8,05 and 41,38±9,7 olarak saptandı (p<0,01). Büyüteçli gözlük kullanılan grupta lefosel oluşumu görülmezken, kullanılmayan grupta 5 (%27,8) hastada lenfosel izlendi. Sonuç: Jinekolojik onkoloji cerrahları büyüteçli gözlük kullanımından fayda görebilir dolayısıyla ekipmanlarına bu gözlükleri ekleyebilirler. Jinekolojik kanser cerrahisinde büyüteçli gözlük kullanımı ile lenfosel gelişimi, toplam drenden gelen miktar, drenaj süresi ve kullanılan hemoklip sayısı azalabilir.
Objective: In this study, we aimed to investigate the role of peripheral blood parameters and the systemic inflammatory index (SII) in the diagnosis of hyperemesis gravidarum (HG) and whether they have a predictive value in determining the length of hospital stay and the risk of rehospitalization in HG cases. Materials and methods: In the retrospective study, pregnant women who were hospitalized due to HG (n = 112) and pregnant women who were completely healthy (n = 112) were matched for gestational age. Peripheral blood inflammation parameters of the entire study group were evaluated. The length of hospital stay and rehospitalization rate for HG cases were recorded. A total of 224 patients, 112 (50%) in the control group and 112 (50%) in the HG group were included in the study. There was a positive correlation between increased ketonuria and length of hospitalization, peripheric blood parameters, and SII. The degree of ketonuria was found to be statistically insignificant in determining the risk of rehospitalization (p = 0.927). About 28.57% (n = 32) of all HG cases were readmitted to the hospital. When the length of hospital stay was considered, SII was found to be statistically significant in hospitalizations lasting more than 2 days (p = 0.001), but not in rehospitalizations (p = 0.3). Conclusion: SII is significant in diagnosing and determining hospitalization of HG. It is sufficient to determine the length of hospital stay but not rehospitalization risk, which is an indicator of disease severity. Key words: hyperemesis gravidarum – hospitalization – inflammation markers – systemic inflammatory index
Objective Early diagnosis and treatment are critical to minimize the complications of gestational diabetes mellitus (GDM). Therefore, the present study aimed to determine whether first-trimester screening test biochemical markers could be an early predictive model for GDM. Material and Method: This retrospective study was performed by accessing the electronic media data of 116 pregnant women who underwent first-trimester screening tests at the 11th-14th weeks of gestation and were diagnosed with GDM at the 24th-28th weeks and 65 pregnant women who did not receive this diagnosis. Demographic characteristics of GDM and control groups, first-trimester screening test biochemical markers, oral glucose tolerance test (OGTT), and hemoglobin A1c values were recorded, and intergroup comparison was made. Results There was no statistically significant difference between the groups regarding first-trimester biochemical markers (p > 0.05). A negative correlation was determined between PAPP-A and free hCG multiple of median (MoM) values and OGTT fasting value (p < 0.05). Conclusion In this study, we concluded that first-trimester biochemical markers could not predict the development of GDM.
Purpose: This study aimed to investigate the surgical outcomes and safety of cesarean section myomectomies. Methods: This retrospective study was performed between January 2015 and August 2022, at a single university hospital. Pregnant women diagnosed with myoma uteri who underwent C/S (cesarean section) myomectomy and pregnant women without myoma as the control group and only underwent C/S were included in the study. Patients' age, gravida, parity, abortion, body mass index (BMI), delivery week, previous delivery type, myoma size, type, number, localization, preoperative and postoperative hemoglobin (Hb) values and postoperative Hb changes, operation time, hospital stay, blood transfusion need and amount, and postoperative complications were recorded from the hospital archive system. The obtained data were compared between the two groups. Results: A total of 283 patients underwent C/S myomectomy and 324 patients who did not have myoma underwent only C/S. Duration of operation, length of hospital stay, postoperative blood transfusion need and amount of blood transfusion, preoperative Hb, and change of Hb values were statistically significantly higher in the C/S myomectomy group (p<0.01, p<0.01, p=0.005, p= 0.006, p<0.01, p<0.01, respectively). A statistically significant weak positive correlation was observed between fibroid size and hospital stay (ρ=0.133). There was a statistically significant weak positive correlation between the size of myoma and the amount of blood transfused (ρ=0.120). Conclusion: Myomectomy during cesarean section has a low complication rate and saves patients from the necessity of a second operation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.